Odyssey Therapeutics, Inc. (ODTX) Market Cap
- 2026-09-03: Market Cap $1.27B.
- 2026-08-03: Market Cap $871.3M.
- 2026-06-30: Market Cap $896.05M.
- 2026-06-12: Market Cap $811.73M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2026-06-12 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|---|
| 2026-09-03 | $1.27B |
| 2026-08-03 | $871.3M |
| 2026-06-30 | $896.05M |
| 2026-06-12 | $811.73M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |